Abstract. Radiotherapy has long been considered as the mainstay of treatment for nasopharyngeal carcinoma (NPC). However, locoregional recurrence or distant metastasis may occur in some patients due to the radiation resistance of cancer cells. Autophagy plays a vital role in protecting cells against radiation. However, the mechanism of autophagy in radiation therapy remains obscure. In the present study, we demonstrated that suppression of autophagy related 5 (Atg5) aggravated ionizing radiation (IR)-induced DNA damage and apoptosis in human NPC cells without accelerating the cell cycle, whereas regulation of the cell cycle has been widely regarded as the most important determinant of IR sensitivity. Further study showed that inhibition of autophagy suppressed the mRNA expression of Rad51, a key protein of homologous recombination that has been demonstrated to play a critical role in the repair of DNA double-strand breaks induced by radiation. Moreover, suppression of Atg5 had no impact on the radiosensitivity when cells were pre-treated by the Rad51 inhibitor, and the enhanced radiosensitivity by Atg5 suppression was reversed by overexpression of Rad51 in human NPC cells. Our results suggest that inhibition of autophagy enhances the susceptibility of NPC cells to radiation by reducing Rad51 expression. Therefore, Rad51 targeted therapy may be investigated as a potential novel agent for the adjuvant treatment of traditional radiation of NPC.
Introduction
Nasopharyngeal carcinoma (NPC) is rare in most populations, although its incidence is particularly high among Asians, particularly in Southern China with an age standardized incidence rate of ~25 cases per 100,000 individuals per year (1) . As a traditional treatment modality, radiotherapy remains the mainstay of treatment for NPC due to its radiosensitivity, even though it has been applied for cancer therapy for more than a century. If diagnosed and treated at an early stage, most NPC patients can be cured. However, locoregional recurrence or distant metastasis may occur in some patients after primary radiotherapy or chemo-irradiation due to the radiation resistance of cancer cells (2) . Due to the presence of tumor cell heterogeneity, cancer cells may exhibit different degrees of radiosensitivity even when they are of the same histological differentiation status, which may contribute to the poor overall survival of NPC patients after recurrence. It follows, therefore, that the development of novel therapeutic strategies to overcome radioresistance and enhance radiosensitivity of NPC are urgently needed.
In regards to the primary mechanism of radiation-induced cell death, apoptosis is not the predominant form of cell death, accounting for only 20% of death (3) . Another cell death pathway, namely autophagy, has emerged as a crucial mechanism of tumor cell death induced by radiation (4) . Autophagy, a multi-step process that involves degradation of long-lived cellular proteins and organelles, is a genetically programmed, highly conserved process that occurs in eukaryotes from yeast to mammals. Recently, studies have shown that autophagy plays a vital role in protecting cells against adverse conditions (5-7), including irradiation (8) . Inhibition of autophagy plays an active role in radiosensitization in several cancer cell types (9) as well as in NPC cells (10) . Although many studies have rigorously attempted to elucidate the mechanism of autophagy in cancer treatments, it remains unclear.
DNA double-strand breaks (DSBs) are the most critical event in ionizing radiation (IR)-induced cell death and can be efficiently repaired by DNA homologous recombination, which is essential for maintaining genomic stability after IR, while Rad51 is a key protein of homologous recombination in resynthesizing the damaged region of the DNA (11) . Overexpression of Rad51 may be a possible mechanism with which to suppress recombination defects and increase the resistance of mammalian cells to IR (12) , suggesting that Rad51 expression may play an essential role in radioresistance.
Previous research has demonstrated that homologous recombination may mediate cellular resistance to radiation therapy (13) , and inhibition of autophagy contributes to the radiosensitivity of CNE-2 cells (14) . Therefore, we hypothesized that inhibition of autophagy could enhance the radiosensitivity of NPC cells by influencing the DNA homologous recombination system. To test this hypothesis, we investigated the effect of autophagy inhibition on the radiosensitivity of NPC cells and elucidated the role of Rad51 in the regulation of radiosensitivity.
Materials and methods
Cell culture and irradiation conditions. The human NPC cell lines, CNE-1 and CNE-2, were obtained from the Chinese Academy of Sciences Cell Bank and were cultured in Roswell Park Memorial Institute (RPMI)-1640 medium supplemented with 10% fetal bovine serum, 100 u/ml of penicillin and 100 µg/ml of streptomycin (all from Invitrogen, Carlsbad, CA, USA). Cultures were maintained in a humidified atmosphere of 5% CO 2 at 37˚C. 3-Methyladenine (3-MA) and chloroquine (CQ) were obtained from Sigma-Aldrich (Shanghai, China). RI-1 was purchased from ChemBridge Corp. (San Diego, CA, uSA). BO2 was purchased from Chief-East Tech Co., Ltd. (Beijing, China). All irradiations were delivered using 6-Mv X-rays with a linear accelerator (Elekta, Sweden) with a dose rate of 220 cGy/min; SSD, 100 cm.
shRNA. A scrambled hairpin (SCR) was used as a negative control (Invitrogen), and Stealth RNAi™ shRNA duplex oligoribonucleotides targeting human Atg5 were obtained from Invitrogen. The sequence of SCR-shRNA was CCT ACG CCA CCA ATT TCG T; Atg5-1-shRNA was ATT GGC TCA ATT CCA TGA ATC and Atg5-2-shRNA was AAG CAA ATA GTA TGG TTC TGC. The shRNA was transfected into CNE1 and CNE2 cells using shRNA transfection reagent (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, uSA) according to the manufacturer's protocol.
Cell viability assay. The measurement of the viable cell mass was assessed by the Cell Counting Kit-8 (Dojin Laboratories, Kumamoto, Japan), as previously described (15) .
Real-time PCR assay. Cells were collected to extract the total cellular mRNA using TRIzol reagent (Invitrogen). cDNA was synthesized using Moloney murine leukemia virus reverse transcriptase (Promega, Madison, WI, uSA) and 2 µg of total RNA and oligo(dT) 18 primers. Two-microliter aliquots of cDNA were used for PCR amplification. Real-time PCR was performed in triplicate using the SYBR PrimeScript RT-PCR kit (Takara, Dalian, China). The sequences of the Atg5 primers listed were TGG ATT TCG TTA TAT CC CCT TT AG (sense) and CCT AGT GTG TGC AAC TGT CCA (antisense); the sequences of the Rad51 primers listed were 5'-TGG CCC ACA ACC CAT TTC AC-3' (sense) and 5'-TCA ATG TAC ATG GCC TTT CCT TCA C-3' (antisense). Total sample RNA was normalized to endogenous human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. Thermocycler conditions included an initial hold at 50˚C for 2 min and then 95˚C for 10 min; this was followed by a two-step PCR program of 95˚C for 15 sec and 60˚C for 60 sec repeated for 40 cycles on an Mx4000 system (Stratagene, La Jolla, CA, uSA), on which data were collected and quantitatively analyzed. The expression level of mRNA was presented as fold-change relative to an untreated control.
Western blot analysis. Cells were washed in PBS solution, and the protein was extracted according to an established protocol. Nuclear extract proteins were quantified using the Bio-Rad protein assay. Proteins were then mixed with Laemmli sample buffer, heated at 65˚C for 10 min, loaded (20 µg/sample), separated by SDS-polyacrylamide gel (7.5%) electrophoresis under denaturing conditions and electroblotted on nitrocellulose membranes. The nitrocellulose membranes were blocked by incubation in blocking buffer (1% BSA in Tris-buffered saline, 0.1% Tween-20), incubated with the anti-Atg5 antibody (1:500 polyclonal; Bethyl), washed and incubated with the anti-rabbit peroxidase-conjugated secondary antibody (1:10,000; Sigma). Signals were visualized by chemiluminescent detection. Blots were quantified using Quantity One software (Bio-Rad), and Atg5 (Epitomics, Inc., uSA) expression (peak intensity) was normalized to values in the control group. Equal loading of samples was verified by Coomassie blue staining of simultaneously run gels. Gels were run four times, and the images shown are representative.
Cell cycle analysis by flow cytometry. Approximately 1x10
6 cells were collected and fixed overnight in 70% ethanol at 4˚C. Cells were then washed in PBS and stained with PI (Sigma) in the presence of DNase-free RNase. After a 30-min incubation at room temperature in the dark, cells were filtered through a 40-µm diameter mesh to remove clumps of nuclei, and cells within the cell cycle compartments (sub-G1, S or G2-M) were determined via a flow cytometer using CellQuest software (BD FACSAria, Becton-Dickinson), acquiring 10,000 events. The percentages of sub-G1 nuclei in the population were determined as apoptosis.
Cell apoptosis assay. Cells (2x10 5 per well) were cultured in 6-well plates to 70-80% confluency. Annexin v-FITC assay was used to measure apoptotic cells by flow cytometry according to the manufacturer's instructions (Nanjing KeyGen Biotech Co., Ltd., Nanjing, China; cat. KGA108). Briefly, cells were collected by trypsinization, washed with ice-cold phosphate-buffered saline (PBS) twice and resuspended in 300 µl 1X binding buffer containing 5 µl Annexin v and 5 µl PI for 30 min at room temperature in the dark. After incubation, at least 10,000 cells were measured on a BD FACSAria flow cytometer. Results are expressed as the percentage of apoptotic cells at early stage (PI-negative and Annexin v-positive). Meanwhile, apoptosis was detected by staining cells with DAPI based on the nuclear morphology, identifying those cells with condensed and fragmented nuclei as apoptotic.
Statistical analysis. All of the experiments were repeated at least three times. The data are expressed as means ± SD. Statistical analysis was performed using the Student's t-test (two-tailed). The criterion for statistical significance was determined to be P<0.05.
Results

Suppression of Atg5 enhances the radiosensitivity of human NPC cells.
To investigate the function of the autophagy related 5 (Atg5) gene in NPC cells after radiation, specific lentivirus-delivered shRNA to the Atg5 gene was used to induce Atg5 gene silencing by a mechanism that involves the RNA-induced silencing complex (RISC). Transduced cells were expanded, and Atg5 mRNA expression was detected by RT-qPCR while the Atg5 protein level was determined by western blot analysis 5 days after infection. As shown in Fig. 1A , silencing of the Atg5 gene markedly decreased the expression of Atg5 mRNA in the CNE-1 cells either transfected with Atg5-targeted shRNA1 or Atg5-targeted shRNA2 compared with the non-targeted shRNA CNE-1 cells and control cells. Similarly, transduction of CNE1 cells with the Atg5-shRNA1 and Atg5-shRNA2 construct virus resulted in nearly complete elimination of Atg5 protein expression (Fig. 1C) . In contrast, the levels of Atg5 protein in cells transduced with the lentiviral vector including the non-specific construct shRNA sequence and control cells did not exhibit an obvious change when compared with GAPDH. Similar results were observed in the CNE-2 cells (Fig. 1B and D) . The results above suggest that silencing of the Atg5 gene reduced the autophagy of NPC cells.
It has been demonstrated that cells die mainly via two pathways, necrosis and apoptosis (16) . Ionizing radiation (IR) kills cancer cells mainly through the induction of DNA doublestrand breaks (DSBs), apoptosis as well as autophagy, whereas autophagy is widely considered to be a protective mechanism against IR. Thus, we hypothesized that autophagy may protect NPC cells from IR-induced cell death by reducing apoptosis and DNA damage. To test this, we further investigated the effect of Atg5 silencing on IR-induced cell apoptosis and DNA damage. Forty-eight hours after 4-Gy X-ray irradiation treatment, cell viability was evaluated by the CCK-8 assay. As shown in Fig. 2A and B, following the silencing of the Atg5 gene, the cell viability of CNE-1 and CNE-2 cells significantly decreased compared with that of the scrambled and control cells.
The decrease in the viability of the cells transfected with Atg5-targeted shRNA indicated an increase in cell death of NPC cells after radiation. Apoptosis, known as type I programmed cell death, could underlie the biological function of radiation. We investigated whether there was an enhancement of cell apoptosis induced by radiation after Atg5 silencing. To evaluate apoptosis, the percentage of apoptotic cells was assessed by flow cytometry with Annexin V/PI double staining analysis. Results showed that CNE-1 cells transfected with the Atg5-targeted shRNA had a higher proportion of apoptotic cells (Fig. 2C ) compared to that of cells transfected with the non-targeted shRNA and control cells. Similar data were obtained using CNE-2 cells (Fig. 2D) .
The formation of γ-H2AX, namely phosphorylation of a histone protein H2AX, indicates the early response of cells to IR-induced DNA damage (17) . γ-H2AX is commonly accepted as a biomarker that indicates the presence of a DSB. Hence, we detected the protein level of γ-H2AX to confirm the DNA damage after radiation in NPC cells. Western blot analysis showed that the protein level of γ-H2AX in the CNE1 and CNE2 cells was increased in all experimental groups after IR (Fig. 2E and F) . However, a higher increase in the protein level of γ-H2AX was observed as the cells were pre-interfered by Atg5-targeted shRNA. Together, the results suggest that suppression of Atg5, to some extent, enhanced the susceptibility of NPC cells to radiation.
Inhibition of autophagy decreases the expression of Rad51.
The above data confirmed that suppression of Atg5 increased the susceptibility of NPC cells to radiation, while the mechanism remains unclear. Radiation induces G2/M phase arrest in various types of cancer cells (18, 19) . This results in enhanced radiosensitivity of cancer cells for the reason that cells are most radiosensitive in the M and G2 phases. Therefore, we aimed to ascertain whether the radiosensitization effect of Atg5 silencing was due to G2/M phase arrest. Contrary to our expectation, cell cycle analysis by flow cytometric measurement revealed that suppression of Atg5 led to cell cycle arrest in the G1 phase where cells are less radiosensitive, while the percentage of cells in the G2/M phase was decreased dramatically in the CNE-2 cells; both results achieving statistical significance (Fig. 3B) . However, no difference in cell cycle distribution was noted in the CNE-1 cells (Fig. 3A) .
Radiation-induced cell damage mainly results in DNA DSBs (20) . Rad51, a key protein of homologous recombination, has been demonstrated to play a critical role in the repair of DNA DSBs. We aimed to ascertain whether Rad51 is related to the radiosensitization effect following silencing of the Atg5 gene. Thus, expression of Rad51 mRNA in NPC cells was analyzed. The RT-qPCR analysis revealed that the expression of Rad51 mRNA demonstrated a notable rise in the negative control and mock-transfected control cells when treated with radiation. However, when cells were transfected with the Atg5-targeted shRNA, which was proven to inhibit autophagy in the NPC cells, the Rad51 mRNA expression revealed a significant decline both in cells treated with or without radiation when compared with that of the negative control and mock-transfected control cells. Moreover, a greater decrease in the expression of Rad51 mRNA was observed as the cells were subjected to a combined treated with radiation ( Fig. 4A and B) .
To further confirm the effect of autophagy inhibition on Rad51 mRNA expression, the control cells were treated with 3-MA or CQ alone or a combined treatment with irradiation followed by Rad51 mRNA expression analysis with RT-qPCR. Fig. 4C and D shows that the Rad51 mRNA expression levels exhibited a completely positive response which were significantly upregulated when IR was administered to the control cells; however, when the cells were treated with 3-MA or CQ, the expression of Rad51 mRNA showed a marked decline compared to that of the untreated cells. Moreover, the disparity became more marked when cells received IR. Notably, IR barely altered the expression of Rad51 mRNA as long as the cells were treated with 3-MA or CQ. As expected, the effect of autophagy inhibition on the expression of Rad51 was ascertained by 3-MA and CQ, indicating that autophagy inhibition may suppress the expression of Rad51. 
Inhibition of autophagy enhances the sensitivity of NPC cells to IR by reducing Rad51 expression.
Prior studies have demonstrated that B02 is a specific inhibitor of human Rad51 (21), while RI-1 acts as a chemical inhibitor of Rad51 that disrupts homologous recombination in human cells (22) . Thus, to demonstrate the function of Rad51 in the radiosensitivity of NPC cells, we examined the influence of Rad51 suppression on radiation sensitivity by treating NPC cells with B02 or RI-1 1 h before the treatment of 4-Gy irradiation. After 48 h, cell viability was evaluated using the CCK-8 assay. As shown in To further validate the relationship between Rad51 and the radioresistance of NPC cells, CNE1 and CNE2 cells were transfected with the Flag-Rad51 vector. After 48 h, the total protein level of Rad51 was determined by western blot analysis. After the next 48 h when cells were treated by 4-Gy irradiation, cell viability was evaluated by the CCK-8 assay. Western blot analysis confirmed Rad51 overexpression in cells transfected with the Flag-Rad51 vector and the control cells when compared to that of cells transfected with the Atg5-targeted shRNA after irradiation. However, the low expression of Rad51 in cells transfected with the Atg5-targeted shRNA exhibited a reverse upregulation when cells were transfected with the Flag-Rad51 vector ( Fig. 6A and B) . Cell viability assays revealed that the viability of the cells transfected with the Atg5-targeted shRNA was significantly decreased compared to that of the mock-transfected control cells, but showed an increase when cells were transfected with the Flag-Rad51 vector before irradiation, which reversed the enhanced radiosensitivity by Atg5 suppression in the CNE1 and CNE2 cells (Fig. 6C and D) . Taken together, the above data indicate a correlation between a reduced Rad51 protein level and increased radiosensitivity to radiation. Thus, the level of Rad51 protein is inversely correlated with sensitivity to radiation in NPC cells.
Discussion
Autophagy, or ̔self-eating', is a double-edged sword that can both suppress cancer initiation and promote the growth of established cancers. A large body of literature has strived to elucidate the role of autophagy in cancer cells in response to cancer therapy. However, whether autophagy contributes to cell death or rather represents a survival mechanism remains controversial (23, 24) . White revealed that suppression or deficiency of autophagy genes are associated with diseases, including cancer (25) . Anticancer agents, such as tamoxifen (26) , rapamycin (27) , temozolomide (28) and IR (29) , have been reported to induce autophagy. After exposure to IR, autophagy can frequently be observed in cancer cells, and radiosensitivity can be increased by inhibition of autophagy (30) . Consistent with this, in the present study, we showed that inhibition of autophagy by knockdown of Atg5 (Fig. 1) enhanced the cytotoxicity of radiotherapy in CNE-1 or CNE-2 cells, as determined from a markedly decrease in cell viability and a higher proportion of apoptotic cells (Fig. 2) . Our findings were further strengthened by a recent study suggesting that blockade of autophagy by transduction of specific target siRNAs led to downregulation of the autophagy-related genes, beclin 1, atg3, atg4b, atg4c, atg5 and atg12 in cell lines, resulting in enhanced cytotoxicity of radiotherapy in cancer cells. However, its regulatory mechanisms remain elusive.
It has been demonstrated that the factors that influence intrinsic radiosensitivity of cell subpopulations include the level of hypoxia, DNA repair capacity and cell cycle phase. Among these, regulation of the cell cycle may be the most important determinant of ΙR sensitivity (31) . Cells are most radiosensitive in the M and G2 phases, less sensitive in the G1 phase and most radioresistant in the S phase (31) .
However, we found that the enhanced cytotoxicity of radiotherapy in CNE-1 or CNE-2 cells did not involve cell cycle arrest. Suppression of Atg5 only resulted in G1 phase arrest while the percentage of cells in the G2/M phase was significantly reduced in the CNE-2 cells following radiation, yet no difference in cell cycle distribution in CNE-1 cells was detected (Fig. 3) . Explanation of this may include the short time of irradiation for only 48 h in our experiment. This may not have been long enough to induce significant cell cycle blockage and the cell type and the radiation dose used must be taken into consideration. Therefore, in the present study, cell cycle arrest was not the main mechanism of radiosensitivity in NPC cells.
It has been reported that ionizing radiation mainly results in the induction of DNA DSBs if left unrepaired (32) , while Rad51 has been demonstrated to be the central player in the initiation of homologous recombination that plays a critical role in the repair of DNA DSBs. Rad51 is not only involved in the progression of carcinogenesis but also in the resistance to anticancer treatments (33) . Enhanced Rad51 protein expression can influence the chemoradiotherapy treatment outcome as well as potentiate radioresistance in tumor cells (34) . Further investigation by us indicated that inhibition of autophagy with Atg5-targeted shRNA and an autophagy inhibitor both resulted in decreased expression of Rad51, yet exhibited no change even when cells were treated with IR (Fig. 4) . These data indicate that inhibition of autophagy impairs the survival mechanism of NPC cells after radiation by reducing Rad51 expression. Thus, we hypothesized that suppression of Rad51 expression rather than cell cycle blockage is a possible mechanism for autophagy-inhibited induced radiosensitization in NPC cells.
For characterizing the role of Rad51, CNE1 and CNE2 cells were treated with RI-1or B02 prior to irradiation. Regardless of whether cells were pre-treated with the Rad51 inhibitor or subjected to knockdown of Atg5, the cell viability was markedly decreased when compared to the scrambled cells without treatment by the Rad51 inhibitor. Moreover, the extent of cell viability was decreased between cells transfected with the Atg5-targeted shRNA and the scrambled cells and was not meaningful by statistical analysis when cells were pre-treated with B02 or RI-1 ( Fig. 5A and B) . These results indicate that the target by which the inhibition of autophagy mediates the radioresistance of NPC cells may be the same as that of B02 and RI-1. Furthermore, the upregulation of Rad51 protein by transfecting the Flag-Rad51 vector into CNE-1 and CNE-2 cells reversed the enhanced radiosensitivity by Atg5 suppression with increased cell viability to radiation (Fig. 6C and D) . Corresponding to our results, previous reseach concluded that overexpression of Rad51 contributes to the resistance of IR and other DNA-damaging agents (12) , while downregulation of Rad51 protein may sensitize tumor cells to IR (35) . These results indicate that Rad51 may not only be involved in the resistance to radiation which results in local residue but also in the locoregional recurrence or distant metastasis of NPC. Nevertheless, the interaction between Rad51 and autophagy in the radiation therapy of NPC is complex and further studies are warranted to support the conclusion.
In summary, our study provides compelling data supporting our hypothesis that inhibition of autophagy enhances the radiosensitivity of NPC cells by reducing Rad51 expression. Thus, the autophagic process of NPC cells is a self-protective mechanism against radiation. Rad51 targeted therapy may be investigated as a potential novel agent for the adjuvant treatment of traditional radiation of NPC, particularly to ascertain whether their combination and maintenance treatment of Rad51 targeted therapy following radiation can enhance the therapeutic effect of radiation, in order to minimize locoregional recurrence or distant metastasis and maximize the outcome of NPC.
